PPA
AGRX

Parametric Portfolio Associates’s Agile Therapeutics AGRX Stock Holding History

Parametric Portfolio Associates’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6
Closed -$17K – 3689
2021
Q2 		$17K Buy
+6
New +$19.8K ﹤0.01% 3557
2018
Q2 		– Sell
-5
Closed -$27K – 3963
2018
Q1 		$27K Sell
5
-1
-17% -$6.61K ﹤0.01% 3921
2017
Q4 		$32K Hold
6
– – ﹤0.01% 3885
2017
Q3 		$53K Sell
6
-1
-14% -$7.68K ﹤0.01% 3992
2017
Q2 		$55K Sell
7
-3
-30% -$20.8K ﹤0.01% 3960
2017
Q1 		$63K Buy
+10
New +$50.3K ﹤0.01% 3724

Other funds holding AGRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parametric Portfolio Associates's AGRX Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Agile Therapeutics (AGRX) in Q3 2021, closing a stake of 6 shares — an estimated $17K sold.

Parametric Portfolio Associates first reported a position in AGRX in Q1 2017 and held it in 6 quarters. The position peaked at $63K in Q1 2017. 49 funds tracked by Wall St. Rank hold AGRX as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining Agile Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 6 Agile Therapeutics shares in Q3 2021, an estimated $17K.
  • Parametric Portfolio Associates first reported a position in Agile Therapeutics in Q1 2017 and held it in 6 quarters.
  • Parametric Portfolio Associates's Agile Therapeutics position peaked at $63K in Q1 2017.
  • 49 funds tracked by Wall St. Rank held Agile Therapeutics as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.